---
figid: PMC7256023__18_2019_3398_Fig1_HTML
figlink: pmc/articles/PMC7256023/figure/Fig1/
number: F1
caption: TGFβ-induced epithelial-to-mesenchymal transition. TGFβ signaling can be
  activated by TGFβ ligands and activate both canonical (blue) and non-canonical pathways
  (grey). In the canonical SMAD pathway, TGFβR2 activated TGFβR1 phosphorylates SMAD2
  and SMAD3, which subsequently form a complex with SMAD4 and translocate to the nucleus.
  Upon DNA binding, the SMAD complex activates drivers of EMT (SNAI1/2, ZEB1/2 and
  TWIST1/2) as well as negative feedback component SMAD7. SMAD7 negative feedback
  regulates TGFβ signaling via recruiting the E3 ubiquitin ligase SMURF2 to activated
  TβR1/2 receptors and then targets the receptors for degradation. SMAD-independent
  activation of PI3K/AKT, RHO and RAS/MAPK pathways by TGFβ are non-canonical effectors
  also involved in EMT and survival. Cancer cells undergoing EMT lose epithelial properties,
  including cell–cell adhesion, apical–basal polarity and the decrease expression
  of epithelial genes, i.e. E-cadherin, ZO-1, laminin-1, occludin, claudin. Subsequently,
  cancer cells acquire migratory mesenchymal characteristics, involving tight-junction
  dissociation and increased expression of mesenchymal markers, i.e. N-cadherin, vimentin
  and fibronectin
pmcid: PMC7256023
papertitle: TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal
  transition in cancer.
reftext: Wan Hua, et al. Cell Mol Life Sci. 2020;77(11):2103-2123.
pmc_ranked_result_index: '9957'
pathway_score: 0.954843
filename: 18_2019_3398_Fig1_HTML.jpg
figtitle: TGFBeta-induced epithelial-to-mesenchymal transition
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7256023__18_2019_3398_Fig1_HTML.html
  '@type': Dataset
  description: TGFβ-induced epithelial-to-mesenchymal transition. TGFβ signaling can
    be activated by TGFβ ligands and activate both canonical (blue) and non-canonical
    pathways (grey). In the canonical SMAD pathway, TGFβR2 activated TGFβR1 phosphorylates
    SMAD2 and SMAD3, which subsequently form a complex with SMAD4 and translocate
    to the nucleus. Upon DNA binding, the SMAD complex activates drivers of EMT (SNAI1/2,
    ZEB1/2 and TWIST1/2) as well as negative feedback component SMAD7. SMAD7 negative
    feedback regulates TGFβ signaling via recruiting the E3 ubiquitin ligase SMURF2
    to activated TβR1/2 receptors and then targets the receptors for degradation.
    SMAD-independent activation of PI3K/AKT, RHO and RAS/MAPK pathways by TGFβ are
    non-canonical effectors also involved in EMT and survival. Cancer cells undergoing
    EMT lose epithelial properties, including cell–cell adhesion, apical–basal polarity
    and the decrease expression of epithelial genes, i.e. E-cadherin, ZO-1, laminin-1,
    occludin, claudin. Subsequently, cancer cells acquire migratory mesenchymal characteristics,
    involving tight-junction dissociation and increased expression of mesenchymal
    markers, i.e. N-cadherin, vimentin and fibronectin
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - SMURF2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - SMAD7
  - AKT2
  - AKT3
  - AKT1
  - HRAS
  - KRAS
  - NRAS
  - SMAD2
  - SMAD3
  - RHO
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - SMAD4
  - ZEB1
  - ZEB2
  - TWIST2
  - TWIST1
  - SNAI2
  - SNAI1
  - CDH1
  - TJP1
  - CDH2
  - TGFBR1
genes:
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: SMURF2
  symbol: SMURF2
  source: hgnc_symbol
  hgnc_symbol: SMURF2
  entrez: '64750'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: (SMAD7
  symbol: SMAD7
  source: hgnc_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SMAD2)
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: RHO
  symbol: RHO
  source: hgnc_symbol
  hgnc_symbol: RHO
  entrez: '6010'
- word: (МЕК)
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: (МЕК)
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SMAD3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: ZEB1/2
  symbol: ZEB1
  source: hgnc_symbol
  hgnc_symbol: ZEB1
  entrez: '6935'
- word: ZEB1/2
  symbol: ZEB2
  source: hgnc_symbol
  hgnc_symbol: ZEB2
  entrez: '9839'
- word: TWIST1/2
  symbol: TWIST2
  source: hgnc_symbol
  hgnc_symbol: TWIST2
  entrez: '117581'
- word: TWIST1/2
  symbol: TWIST1
  source: hgnc_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
- word: SNAI1/2
  symbol: SNAI2
  source: hgnc_symbol
  hgnc_symbol: SNAI2
  entrez: '6591'
- word: SNAI1/2
  symbol: SNAI1
  source: hgnc_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: SMAD4SNAI1/2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: TWIST1/2)
  symbol: TWIST1
  source: hgnc_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
- word: ZEB1/2
  symbol: ZEB1
  source: hgnc_symbol
  hgnc_symbol: ZEB1
  entrez: '6935'
- word: ZEB1/2
  symbol: ZEB2
  source: hgnc_symbol
  hgnc_symbol: ZEB2
  entrez: '9839'
- word: (SNAI1/2)Epithelial
  symbol: SNAI1
  source: hgnc_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: ZEB1/2Epithelialgenes(SNAI1/2)EpithelialgenesTWIST1/2)Mesenchymalgenes
  symbol: ZEB1
  source: hgnc_symbol
  hgnc_symbol: ZEB1
  entrez: '6935'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: E-cadherin+
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: ZO-1
  symbol: ZO-1
  source: hgnc_alias_symbol
  hgnc_symbol: TJP1
  entrez: '7082'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: N-cadherin+
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: ZO-1
  symbol: ZO-1
  source: hgnc_alias_symbol
  hgnc_symbol: TJP1
  entrez: '7082'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: N-cadherin+
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: TGFBR1
  symbol: TGFBR1
  source: hgnc_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
chemicals: []
diseases: []
figid_alias: PMC7256023__F1
redirect_from: /figures/PMC7256023__F1
figtype: Figure
---
